MedGen, Inc. engages in the manufacture, sale, and licensing of healthcare products. Its product portfolio includes SNORenz, SNORenz Night-Time, Sombium, Focamine, Wide Awake, Stem Intense, and Relaxapro. The company was founded in October 1996 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of MedGen Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. MedGen Inc market cap is $3,010.00.